Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study

[1]  M. Levi,et al.  Risk of prostate cancer in low‐dose aspirin users: A retrospective cohort study , 2016, International journal of cancer.

[2]  Evelyn Whitlock,et al.  Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.

[3]  W. Willett,et al.  Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. , 2016, JAMA oncology.

[4]  Yin Cao,et al.  Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.

[5]  R. Erichsen,et al.  Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk , 2015, Annals of Internal Medicine.

[6]  H. Grönberg,et al.  The risk of prostate cancer for men on aspirin, statin or antidiabetic medications. , 2015, European journal of cancer.

[7]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[8]  N. Cook,et al.  Estimates of benefits and harms of prophylactic use of aspirin in the general population , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  G. Andriole,et al.  Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study , 2014, Clinical Cancer Research.

[10]  Xiangyi Zheng,et al.  Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk , 2014, World Journal of Surgical Oncology.

[11]  Timothy J Wilt,et al.  Prevention and early detection of prostate cancer. , 2014, The Lancet. Oncology.

[12]  T. Tammela,et al.  Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial , 2014, British Journal of Cancer.

[13]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[14]  J. Hallas,et al.  Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012 , 2014, Clinical epidemiology.

[15]  Junhua Zheng,et al.  Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies , 2014, International Urology and Nephrology.

[16]  Shan Li,et al.  Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis , 2014, BMC Medicine.

[17]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[18]  Lau Caspar Thygesen,et al.  When the entire population is the sample: strengths and limitations in register-based epidemiology , 2014, European Journal of Epidemiology.

[19]  R. Day,et al.  Non-steroidal anti-inflammatory drugs (NSAIDs) , 2013, BMJ.

[20]  A. Tjønneland,et al.  Prostate cancer in Denmark 1978–2009 — trends in incidence and mortality , 2013, Acta oncologica.

[21]  Q. Ding,et al.  Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis. , 2013, Diabetes research and clinical practice.

[22]  T. Tammela,et al.  Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. , 2013, European journal of cancer.

[23]  S. Friis,et al.  Completeness of prostate cancer staging in the Danish Cancer Registry, 2004–2009 , 2012, Clinical epidemiology.

[24]  P. Rothwell,et al.  Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. , 2012, The Lancet. Oncology.

[25]  M. Thun,et al.  The role of aspirin in cancer prevention , 2012, Nature Reviews Clinical Oncology.

[26]  S. Gallus,et al.  Aspirin and urologic cancer risk: an update , 2012, Nature Reviews Urology.

[27]  C. Pedersen,et al.  The Danish Civil Registration System , 2011, Scandinavian journal of public health.

[28]  L. Thygesen,et al.  Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving , 2011, Scandinavian journal of public health.

[29]  B. Bjerregaard,et al.  The Danish Pathology Register , 2011, Scandinavian journal of public health.

[30]  Marianne Lundkjær Gjerstorff,et al.  The Danish Cancer Registry , 2011, Scandinavian journal of public health.

[31]  Mikkel Baadsgaard,et al.  Danish registers on personal income and transfer payments , 2011, Scandinavian journal of public health.

[32]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[33]  J. Hallas,et al.  The Danish National Prescription Registry , 2011, Scandinavian journal of public health.

[34]  Vibeke Jensen,et al.  Danish education registers , 2011, Scandinavian journal of public health.

[35]  Stacey A. Kenfield,et al.  Long‐term aspirin use and the risk of total, high‐grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006 , 2011, International journal of cancer.

[36]  F. Hamdy,et al.  Associations of aspirin, nonsteroidal anti‐inflammatory drug and paracetamol use with PSA‐detected prostate cancer: Findings from a large, population‐based, case–control study (the ProtecT study) , 2011, International journal of cancer.

[37]  J. Potter,et al.  Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[38]  E. Franco,et al.  Use of nonsteroidal anti‐inflammatory drugs and prostate cancer risk: A meta‐analysis , 2010, International journal of cancer.

[39]  P. Nelson,et al.  Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. , 2010, American journal of epidemiology.

[40]  Timo Ylikomi,et al.  Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial Cells at therapeutic concentrations , 2009, The Prostate.

[41]  M. Thun,et al.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.

[42]  E. Klein,et al.  Risk factors for prostate cancer , 2009, Nature Clinical Practice Urology.

[43]  Leslie H. Sobin,et al.  Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley , 2009 .

[44]  U. Vogel,et al.  Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study , 2009, Cancer Causes & Control.

[45]  Randall Harris,et al.  Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. , 2007, Sub-cellular biochemistry.

[46]  H. Sørensen,et al.  Cancer risk among users of neuroleptic medication: a population-based cohort study , 2006, British Journal of Cancer.

[47]  Michael J Thun,et al.  A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. , 2005, Journal of the National Cancer Institute.

[48]  A. Sabichi,et al.  COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. , 2004, Seminars in oncology.

[49]  L. G. García Rodríguez,et al.  Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[51]  H. Sørensen,et al.  Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. , 2004, Diabetes care.

[52]  J. Olsen,et al.  A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin , 2003, British Journal of Cancer.

[53]  R. Lancashire,et al.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.

[54]  A. Norrish,et al.  Non‐steroidal anti‐inflammatory drugs and prostate cancer progression , 1998, International journal of cancer.

[55]  H. Storm,et al.  The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.

[56]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[57]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .